HER2-PET Imaging in HER2-low Breast Cancers

NCT06732336 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Metastatic

Interventions

DIAGNOSTIC_TEST: 89Zr-trastuzumab

Sponsor

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Collaborators

[object Object]